Sherin Al - Safadi

Sherin Al-Safadi, MSc, MBA, PhD, currently serves as Vice President of Medical & Corporate Affairs at Radiopharm Theranostics since July 2023. Sherin co-founded and has been the President of Fondation Amal since February 2012. Sherin also holds the position of US Ambassador at the Syrian Professional Network since April 2021. Previously, Sherin was Vice President of Medical Affairs at POINT Biopharma from December 2021 to March 2023 and held various leadership roles in Global Medical Affairs at Bayer Pharmaceuticals from August 2014 to November 2021. Additional experience includes working as an Independent Consultant, Chief Medical Officer at Biova, Molecular Neurobiologist at the Center for Studies in Behavioral Neurobiology, and Researcher in Oncology Drug Development at McGill University Health Centre. Educational qualifications include a Bachelor's Degree in Anatomy & Cell Biology and a Master's Degree in Pharmacology & Therapeutics from McGill University, along with two MBAs and a Ph.D. in Neurobiology from Concordia University.